These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38967908)

  • 61. Health Technology Assessment in Thailand: Institutionalization and Contribution to Healthcare Decision Making: Review of Literature.
    Leelahavarong P; Doungthipsirikul S; Kumluang S; Poonchai A; Kittiratchakool N; Chinnacom D; Suchonwanich N; Tantivess S
    Int J Technol Assess Health Care; 2019; 35(6):467-473. PubMed ID: 31190670
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dissemination of health technology assessments: identifying the visions guiding an evolving policy innovation in Canada.
    Lehoux P; Denis JL; Tailliez S; Hivon M
    J Health Polit Policy Law; 2005 Aug; 30(4):603-41. PubMed ID: 16318164
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations.
    Elvidge J; Summerfield A; Knies S; Németh B; Kaló Z; Goettsch W; Dawoud DM;
    Int J Technol Assess Health Care; 2023 Apr; 39(1):e24. PubMed ID: 37092749
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making.
    Gordon J; Stainthorpe A; Jones B; Jacob I; Hertel N; Diaz J; Yuan Y; Borrill J
    Pharmacoecon Open; 2021 Dec; 5(4):701-713. PubMed ID: 34216002
    [TBL] [Abstract][Full Text] [Related]  

  • 65. When health technology assessment is confidential and experts have no power: the case of Hungary.
    Csanádi M; Löblová O; Ozierański P; Harsányi A; Kaló Z; McKee M; King L
    Health Econ Policy Law; 2019 Apr; 14(2):162-181. PubMed ID: 29576025
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Health technology assessment and private payers' coverage of personalized medicine.
    Trosman JR; Van Bebber SL; Phillips KA
    J Oncol Pract; 2011 May; 7(3 Suppl):18s-24s. PubMed ID: 21886515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment.
    Hunter A; Facey K; Thomas V; Haerry D; Warner K; Klingmann I; May M; See W
    Front Med (Lausanne); 2018; 5():231. PubMed ID: 30238004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Breaking up is hard to do: why disinvestment in medical technology is harder than investment.
    Haas M; Hall J; Viney R; Gallego G
    Aust Health Rev; 2012 May; 36(2):148-52. PubMed ID: 22624634
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Redefining health technology assessment in Canada: diversification of products and contextualization of findings.
    Lehoux P; Tailliez S; Denis JL; Hivon M
    Int J Technol Assess Health Care; 2004; 20(3):325-36. PubMed ID: 15446762
    [TBL] [Abstract][Full Text] [Related]  

  • 70. History of health technology assessment: Spain.
    Sampietro-Colom L; Asua J; Briones E; Gol J;
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():163-73. PubMed ID: 19538814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Methodological approaches in conducting overviews: current state in HTA agencies.
    Pieper D; Antoine SL; Morfeld JC; Mathes T; Eikermann M
    Res Synth Methods; 2014 Sep; 5(3):187-99. PubMed ID: 26052845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
    Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 74. WHY PATIENTS SHOULD BE INVOLVED IN HEALTH TECHNOLOGY ASSESSMENT.
    Wale J; Scott AM; Hofmann B; Garner S; Low E; Sansom L
    Int J Technol Assess Health Care; 2017 Jan; 33(1):1-4. PubMed ID: 28528585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. USING THE HEALTH TECHNOLOGY ASSESSMENT TOOLBOX TO FACILITATE PROCUREMENT: THE CASE OF SMART PUMPS IN A CANADIAN HOSPITAL.
    Poder TG
    Int J Technol Assess Health Care; 2017 Jan; 33(1):54-62. PubMed ID: 28578750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HTA and its legal issues: a framework for identifying legal issues in health technology assessment.
    Widrig D; Tag B
    Int J Technol Assess Health Care; 2014 Dec; 30(6):587-94. PubMed ID: 25816824
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
    Oortwijn W; Klein P
    Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Health technology assessment, research, and implementation within a health region in Alberta, Canada.
    Lee RC; Marshall D; Waddell C; Hailey D; Juzwishin D
    Int J Technol Assess Health Care; 2003; 19(3):513-20. PubMed ID: 12962337
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN HEALTHCARE SYSTEM IN SLOVENIA.
    Prevolnik Rupel V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):360-364. PubMed ID: 28434423
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.